ArticleJournal of neuro-oncology2022

Postmortem study of organ-specific toxicity in glioblastoma patients treated with a combination of temozolomide, irinotecan and bevacizumab.

Guangrong Lu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.